Lars Öhman
Karo Pharma (Sweden) · 14 works · 4,267 citations · h-index 12
Top works
- Molecular basis of agonism and antagonism in the oestrogen receptor
- The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain
- Brzozowski, A M. et al. Molecular basis of agonism and antagonism in the estrogen receptor. Nature 389, 753-758
- Physiology of cultured animal cells
- Liver-Selective Glucocorticoid Antagonists: A Novel Treatment for Type 2 Diabetes
- Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes
- Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase
- Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma
- Pathways of glutamine metabolism in Spodoptera frugiperda (Sf9) insect cells: evidence for the presence of the nitrogen assimilation system, and a metabolic switch by 1H/15N NMR
- Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance
- Metabolic Engineering of Animal Cellsa
- Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production
- Synthesis and activity of novel bile-acid conjugated glucocorticoid receptor antagonists
- Liver-Selective Glucocorticoid Antagonists: A Novel Treatment for Type 2 Diabetes.